Conversely, higher expression of these markers was associated with better survival rates in the SKCM cohort Consequently, although HLA-A/B/C and LILRA1/LILRA3/LILRB2 were commonly observed in non-responder TIMs, their association with post- ICB patient survival appears to be cancer-specific. Here, LILRB2 is linked to cancer.